Anthralin (1,8-Dihydroxyanthrone) Is a Potent Inhibitor of Leukotriene Production and LTB4-ω Oxidation by Human Neutrophils
- 31 October 1986
- journal article
- research article
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 87 (5) , 624-629
- https://doi.org/10.1111/1523-1747.ep12456188
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Carbon monoxide inhibits ω-oxidation of leukotriene B4 by human polymorphonuclear leukocytes: Evidence that catabolism of leukotriene B4 is mediated by a cytochrome P-450 enzymeBiochemical and Biophysical Research Communications, 1984
- Specific leukotriene formation by purified human eosinophils and neutrophilsFEBS Letters, 1984
- Altered polymorphonuclear leukocyte responses in psoriasis: chemotaxis and degranulationBritish Journal of Dermatology, 1983
- CHEMOTACTIC LEUKOTRIENES IN PSORIASISThe Lancet, 1982
- Calcium stimulation of the 5-lipoxygenase from RBL-1 cellsBiochemical and Biophysical Research Communications, 1982
- Skin permeability of anthralinBritish Journal of Dermatology, 1981
- Endogenous substrates of monooxygenases: Fatty acids and prostaglandinsPharmacology & Therapeutics, 1980
- Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytesNature, 1980
- The Effect of Anthralin and its Derivatives on Epidermal Cell KineticsJournal of Investigative Dermatology, 1975
- Glyceraldehydephosphate Dehydrogenase and Glucose-6-Phosphate Dehydrogenase Activities in Psoriasis and Neurodermatitis and the Effect of DithranolJournal of Investigative Dermatology, 1970